Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Leukemia & Lymphoma
|
September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
Muhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.
Blood Advances
|
February 18, 2026
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?
Flavia Gava, Bonnie Yates, Zhouxin Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
Alan F List, Zhuoxin Sun, Amit Verma, et al.
Blood Advances
|
May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
Talha Badar, Aniko Szabo, Anjali Advani, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia
Grace C Blitzer, Cristina Paz, Annemarie Glassey, et al.
Blood Advances
|
February 11, 2026
Conventional Therapy vs HMA or LDAC ± Venetoclax in Older Adults With AML: Systematic Review and Meta-analysis
Sara Ibrahim, Barbara Burgos-Mansilla, Yetiani Roldan, et al.
Cancer
|
December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia
Talha Badar, Aniko Szabo, Shira Dinner, et al.
Leukemia & Lymphoma
|
November 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)
Robert Jeraj, Fenghai Duan, Ryan J Mattison, et al.
Blood Advances
|
January 15, 2026
Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review & meta-analysis
Maria Jose Oliveros, Saifur R Chowdhury, Yetiani Roldan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2019
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019
Patrick A Brown, Matthew Wieduwilt, Aaron Logan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Leukemia & Lymphoma
|
September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
Muhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.
Blood Advances
|
February 18, 2026
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?
Flavia Gava, Bonnie Yates, Zhouxin Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
Alan F List, Zhuoxin Sun, Amit Verma, et al.
Blood Advances
|
May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
Talha Badar, Aniko Szabo, Anjali Advani, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia
Grace C Blitzer, Cristina Paz, Annemarie Glassey, et al.
Blood Advances
|
February 11, 2026
Conventional Therapy vs HMA or LDAC ± Venetoclax in Older Adults With AML: Systematic Review and Meta-analysis
Sara Ibrahim, Barbara Burgos-Mansilla, Yetiani Roldan, et al.
Cancer
|
December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia
Talha Badar, Aniko Szabo, Shira Dinner, et al.
Leukemia & Lymphoma
|
November 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)
Robert Jeraj, Fenghai Duan, Ryan J Mattison, et al.
Blood Advances
|
January 15, 2026
Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review & meta-analysis
Maria Jose Oliveros, Saifur R Chowdhury, Yetiani Roldan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2019
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019
Patrick A Brown, Matthew Wieduwilt, Aaron Logan, et al.
Page
of 4